- Dose adjustment
- Hematologic ReactionsJAKAVI (ruxolitinib) safety profile – Hematologic Reactions- Hematologic reactions are expected and manageable 1 ... 
- Xolair® (omalizumab)Allergy Asthma Children 6 to < 12 years of age Xolair is indicated as add-on therapy to improve asthma control with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and frequent daytime...
- Ultibro® (indacaterol maleate/ glycopyrronium bromide)Respiratory Pharmaceuticals
- Heart Failure - A Spotlight of Symptoms (Video)- Video Platform Video Management Video Solutions Video Player 
- Clinical Resources: VideosVerify Baseline-Sep 20 NP4- Video Platform Video Management Video Solutions Video Player 
 Verify primary endpoint- Sep 20 NP4- Video Platform Video Management Video Solutions Video Player... 
- Dosing- Dosing & administration - Dosage regimen - General... 
- Safety Profile- Summary of the safety profile - Refer to full prescribing information (Warnings and Precaution... 
- About Galvus- Galvus is a novel oral antidiabetic drugs belongs to the class of DPP4i. Galvus contains Vildagliptin and it is indicated in the treatment of type 2 diabetes mellitus, either as a... 
    ×
              
Ask Speakers
    ×